The main reason for the failure of malignant glioma treatment is local tumor recurrence. Tumor cells in hypoxic microenvironment activate HIF-1 α transcription, and thus promoting tumor invasion and metastasis is one of the important reasons. In our previous study, we clearly established that borneol opens the blood-brain tumor barrier and its related mechanism. However, the effects of borneol on glioma treatment have not yet been elucidated. Therefore, in this study, we evaluated the effects of borneol on cell proliferation and the expression of HIF-1a, mTORC1, eIF4E were by constructing in vivo SD rat brain glioma model and in vitro human primary cultured glioma cell model. Further, we measured the apoptosis effect and mechanism induced by borneol in human primary cultured glioma cells. We found that borneol could induce primary glioma cells apoptosis by suppressing the mTORC1 / eIF4E / HIF-1 α signaling pathway. Further, we also found that borneol could downregulate the expression of Bcl-2 and upregulation the expression of Bax and caspase-3,suggesting that borneol could further regulate the expression of apoptosis-related factors and induce the apoptosis of glioma cells. In conclusion, the findings of the present study suggest that HIF-1α may be a key factor in apoptosis of glioma cells, and mTORC1 / eIF4E / HIF-1a pathway is involved in the apoptosis induced by borneol in malignant glioma. Our results not only reveal the target and molecular mechanism and action of borneol leading to promote apoptosis in glioma cells, but also provide experimental basis and theoretical support for the clinical application of borneol.